Alfamed Fipronil 268 mgSpot-On Solution for Large Dogs

Main information

  • Trade name:
  • Alfamed Fipronil 268 mgSpot-On Solution for Large Dogs
  • Pharmaceutical form:
  • Spot-on solution
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Alfamed Fipronil 268 mgSpot-On Solution for Large Dogs
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • fipronil
  • Therapeutic area:
  • Dogs

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • UK/V/0397/004
  • Authorization date:
  • 21-03-2012
  • EU code:
  • UK/V/0397/004
  • Last update:
  • 09-08-2016

Summary of Product characteristics: dosage,interactions,side effects

Issued:August2012

AN:00104/2011

Page1of7

SUMMARYOFPRODUCTCHARACTERISTICS

1. NAMEOFTHEVETERINARYMEDICINALPRODUCT

ALFAMEDFIPRONIL(BE)/FIPROLINE(HU,RO)/VETFLEA(UK)268mgSpot-on

solutionforlargedogs

2. QUALITATIVEANDQUANTITATIVECOMPOSITION

One2.68mlpipettecontains:

Activesubstance:

Fipronil 268mg

Excipients:

ButyhydroxyanisoleE3200.536mg

ButylhydroxytolueneE3210.268mg

Forafulllistofexcipients,seesection6.1.

3. PHARMACEUTICALFORM

Spot-onsolution.

Clear,colourlesstoyellowsolution.

4. CLINICALPARTICULARS

4.1Targetspecies

Dogs.

4.2Indicationsforuse

Treatmentofflea(Ctenocephalidesspp.)andtick(Dermacentorreticulatus)

infestations.

Insecticidalefficacyagainstnewinfestationswithadultfleaspersistsforupto8weeks.

Theproducthasapersistentacaricidalefficacyforupto4weeksagainstticks

(Rhipicephalussanguineus,Ixodesricinus,Dermacentorreticulatus).Ifticksofsome

species(RhipicephalussanguineusandIxodesricinus)arepresentwhentheproduct

isapplied,alltheticksmaynotbekilledwithinthefirst48hoursbuttheymaybekilled

withinaweek.

TheproductcanbeusedaspartofatreatmentstrategyforthecontrolofFleaAllergy

Dermatitis(FAD)wherethishasbeenpreviouslydiagnosedbyaveterinarysurgeon.

Issued:August2012

AN:00104/2011

Page2of7

4.3Contraindications

Donotuseonpuppieslessthan2monthsoldand/orweighinglessthan2kginthe

absenceofavailabledata.

Donotuseonsick(e.g.systemicdiseases,fever…)orconvalescentanimals.

Donotuseinrabbits,asadversereactionsandevendeathcouldoccur.

Thisproductisspecificallydevelopedfordogs.Donotuseincats,asthiscouldleadto

overdosing.

Donotuseincasesofhypersensitivitytotheactivesubstanceortoanyofexcipients.

4.4Specialwarningsforeachtargetspecies

Shampooinganhourpriortotreatmentdoesnotaffecttheefficacyoftheproduct

againstfleas.

Bathing/immersioninwaterwithintwodaysafterapplicationoftheproductshouldbe

avoided.Weeklyimmersioninwaterforoneminutereducestheperiodofpersistent

insecticidalefficacyagainstfleasbyoneweek.

Theproductdoesnotpreventticksfromattachingtotheanimals.Iftheanimalhasbeen

treatedpriortoexposuretotheticks,thetickswillbekilledinthefirst24-48hoursafter

attachment.Thiswillusuallybepriortoengorgement,minimisingbutnotexcludingthe

riskoftransmissionofdiseases.Oncedead,tickswilloftendropofftheanimal,butany

remainingticksmayberemovedwithagentlepull.

Fleasfrompetsofteninfesttheanimal'sbasket,beddingandregularrestingareassuch

ascarpetsandsoftfurnishingswhichshouldbetreated,incaseofmassiveinfestation

andatthebeginningofthecontrolmeasures,withasuitableinsecticideandvacuumed

regularly.

WhenusedaspartofastrategyforthetreatmentofFleaAllergyDermatitis,monthly

applicationstotheallergicpatientandtootherdogsinthehouseholdare

recommended.

Foroptimalcontroloffleainfestationinmulti-pethousehold,alldogsandcatsinthe

householdshouldbetreatedwithasuitableinsecticide.

4.5Specialprecautionsforuse

Specialprecautionsforuseinanimals

Animalsshouldbeweighedaccuratelypriortotreatment.

Avoidcontactwiththeanimal’seyes.Inthecaseofaccidentaleyecontact,immediately

rinsetheeyeswithcleanwater.

Itisimportanttomakesurethattheproductisappliedtoanareawheretheanimal

cannotlickitoffandtomakesurethatanimalsdonotlickeachotherfollowingtreatment

Donotapplytheproductonwoundsordamagedskin.

Issued:August2012

AN:00104/2011

Page3of7

Specialprecautionstobetakenbythepersonadministeringtheveterinary

medicinalproducttoanimals

Thisproductcancausemucousmembraneandeyeirritation.Therefore,contact

betweentheproductandthemouthoreyesshouldbeavoided.

Inthecaseofaccidentaleyecontact,immediatelyrinsetheeyeswithcleanwater.Ifeye

irritationpersistsseekmedicaladviceandshowthepackageleafletorthelabeltothe

physician.

Donotsmoke,drinkoreatduringapplication.

Avoidcontentscomingintocontactwiththefingers.Ifthisoccurs,washhandswithsoap

andwater.Washhandsafteruse.

Peopleorswithaknownhypersensitivitytofipronilorexcipients(seesection6.1.)

shouldavoidcontactwiththeveterinarymedicinalproduct.

Treatedanimalsshouldnotbehandleduntiltheapplicationsiteisdry,andchildren

shouldnotbeallowedtoplaywithtreatedanimalsuntiltheapplicationsiteisdry.Itis

thereforerecommendedthatanimalsarenottreatedduringtheday,butshouldbe

treatedduringtheearlyevening,andthatrecentlytreatedanimalsshouldnotbeallowed

tosleepwithowners,especiallychildren.

Otherprecautions

Fipronilmayadverselyaffectaquaticorganisms.Dogsshouldnotbeallowedtoswimin

watercoursesfor2daysafterapplication.

Theproductmayhaveadverseeffectsonpainted,varnishedorotherhousehold

surfacesorfurnishings.

4.6Adversereactions(frequencyandseriousness)

Iflickingoccurs,abriefperiodofhypersalivationmaybeobservedduemainlytothe

natureofthecarrier.

Amongtheextremelyraresuspectedadversereactions,transientcutaneousreactions

ontheapplicationsite(skindiscoloration,localalopecia,pruritus,erythema)and

generalpruritusoralopeciahavebeenreportedafteruse.Exceptionally,

hypersalivation,reversibleneurologicsymptoms(hyperesthesia,depression,nervous

symptoms),vomitingorrespiratorysymptomshavebeenobservedafteruse.

4.7Useduringpregnancyandlactation

Laboratorystudiesusingfipronilhavenotshownanyevidenceofteratogenicor

embryotoxiceffect.Studieshavenotbeencarriedoutwiththisproductinpregnantand

lactatingbitches.Useinpregnancyandlactationonlyinaccordancewithprofessional

veterinaryadviceandabenefit/riskassessment.

4.8Interactionwithothermedicinalproductsandotherformsofinteraction

Noneknown.

4.9Amountstobeadministeredandadministrationroute

Issued:August2012

AN:00104/2011

Page4of7

Routeofadministrationanddosage:

Externaluseonly.

Administerbytopicalapplicationtotheskinaccordingtothebodyweightasfollows:

1pipetteof2.68mlperdogweighingover20kgandupto40kgbodyweight.

Methodofadministration:

Holdthepipetteupright.Tapthenarrowpartofthepipettetoensurethatthecontents

arewithinthemainbodyofthepipette.Breakthesnap-offtopofthespot-onpipette

alongthescoredline.

Partthepet’scoatuntilitsskinisvisible.Placethetipofthepipettedirectlyagainstthe

baredskinandsqueezegentlyseveraltimestoemptyitscontentsRepeatthis

procedureatoneortwodifferentpointsalongthepet’sback.

(Note:theshapeofthemarketedpipettescanbedifferentaswellasthepicturesonthe

marketedboxes/packageleaflets.)

Itisimportanttomakesurethattheproductisappliedtoanareawheretheanimal

cannotlickitoff,andtomakesurethatanimalsdonotlickeachotherfollowing

treatment.

Careshouldbetakentoavoidexcessivewettingofthehairwiththeproductsincethis

willcauseastickyappearanceofhairsatthetreatmentspot.However,shouldthis

occur,itwilldisappearwithin24hourspostapplication.

Issued:August2012

AN:00104/2011

Page5of7

Treatmentschedule:

Foroptimalcontroloffleaand/ortickinfestationthetreatmentschedulecanbebased

onthelocalepidemiologicalsituation.

Intheabsenceofsafetystudies,theminimumtreatmentintervalis4weeks.

4.10Overdose(symptoms,emergencyprocedures,antidotes),ifnecessary

Noadverseeffectswereobservedintargetanimalsafetystudiesin2month-old

puppies,growingdogsanddogsweighingabout2kgtreatedwiththetherapeuticdose

onfiveconsecutivedays.Theriskofadverseeffects(seesection4.6)mayincreasein

casesofoverdose.

4.11Withdrawalperiod

Notapplicable.

5. PHARMACOLOGICALPROPERTIES

Pharmacotherapeuticgroup:Ectoparasiticidesfortopicaluse.

ATCvetcode:QP53AX15

5.1Pharmacodynamicproperties

Fipronilisaninsecticideandacaricidebelongingtothephenylpyrazolefamily.Itactsby

inhibitingtheGABAcomplex,bindingtothechloridechannelandtherebyblockingpre-

andpost-synaptictransferofchlorideionsacrosscellmembranes.Thisresultsin

uncontrolledactivityofthecentralnervoussystemanddeathofinsectsoracarids.

Fipronilexhibitsaninsecticidalandacaricidalactivityagainstfleas(Ctenocephalides

spp),ticks(Rhipicephalusspp,Dermacentorspp,IxodessppincludingIxodesricinus)

inthedog.

Fleaswillbekilledwithin24h.Tickswillusuallybekilledwithin48haftercontactwith

Fipronil,howeverifticksofsomespecies(RhipicephalussanguineusandIxodes

ricinus)arealreadypresentwhentheproductisapplied,alloftheticksmaynotbekilled

withinthefirst48hours.

5.2Pharmacokineticparticulars

Fipronilismainlymetabolisedtoitssulfonederivative(RM1602),whichalsopossesses

insecticidalandacaricidalproperties.Theconcentrationsoffipronilonthehair

decreasewithtime.

6. PHARMACEUTICALPARTICULARS

6.1Listofexcipients

ButylhydroxyanisoleE320

Issued:August2012

AN:00104/2011

Page6of7

ButylhydroxytolueneE321

Benzylalcohol

Diethyleneglycolmonoethylether

6.2Incompatibilities

Noneknown.

6.3Shelflife

Shelf-lifeoftheveterinarymedicinalproductaspackagedforsale:2years.

6.4.Specialprecautionsforstorage

Storebelow30°C.Storeinadryplace.Storeintheoriginalpackage.

6.5Natureandcompositionofimmediatepackaging

Whitemulti-layerplasticsingle-dosepipettescontaininganextractiblevolumeof2.68

ml.

Theinternallayersincontactwiththeproductaremadeofpolyacrylonitrile-methacrylate.

Thewhiteexternalcomplexiscomposedofpolypropylene/cyclicolefinecopolymer/

polypropylene.

Boxesof1,2,3,4,6,8,12,24,30,60,90or150pipettes.

Notallpacksizesmaybemarketed.

6.6Specialprecautionsforthedisposalofunusedveterinarymedicinal

productorwastematerialsderivedfromtheuseofsuchproducts

Anyunusedveterinarymedicinalproductorwastematerialsderivedfromsuchveterinary

medicinalproductsshouldbedisposedofinaccordancewithlocalrequirements.

Fipronilmayadverselyaffectaquaticorganisms.Donotcontaminateponds,waterwaysor

ditcheswiththeproductoremptycontainer.

7. MARKETINGAUTHORISATIONHOLDER

ALFAMED

13èmeRue –L.I.D.

06517CarrosCedex

France

8. MARKETINGAUTHORISATIONNUMBER

Vm17902/4023

9. DATEOFFIRSTAUTHORISATION

20August2012

Issued:August2012

AN:00104/2011

Page7of7

10.DATEOFREVISIONOFTHETEXT

August2012

14-12-2018

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

Published on: Thu, 13 Dec 2018 The European Commission asked EFSA for a scientific evaluation on the risks to human health related to the presence of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in food. Regarding PFOS and PFOA occurrence, the final data set available for dietary exposure assessment contained a total of 20,019 analytical results (PFOS n = 10,191 and PFOA n = 9,828). There were large differences between upper and lower bound exposure due to analytical methods with i...

Europe - EFSA - European Food Safety Authority Publications

24-11-2018

The EFSA‐funded collection of dietary and related data in the general population aged 10‐74 years in Greece

The EFSA‐funded collection of dietary and related data in the general population aged 10‐74 years in Greece

Published on: Fri, 23 Nov 2018 The Hellenic Health Foundation received support from the European Food Safety Authority in order to organise a national nutrition survey according to the methodology described in the EFSA Guidance document and to collect food consumption and related information among 780 adolescents, adults and elderly residing permanently in Greece. The EFSA‐funded data collection was largely based on the protocol of a large scale Greek national nutrition and health survey, called HYDRIA....

Europe - EFSA - European Food Safety Authority Publications

19-9-2018

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

Published on: Tue, 18 Sep 2018 00:00:00 +0200 During the years 2012‐2016, the Dutch National Food Consumption survey was conducted in the Netherlands. For the survey, a random sample was drawn from consumer panels stratified by age and gender and maintained representative to the population with regard to region, address density and educational level. Complete results were obtained for 4,313 persons (response rate 65%); including toddlers, children, adolescents, adults and elderly. Pregnant or lactating ...

Europe - EFSA - European Food Safety Authority Publications

25-6-2018

Commissie onderzoek fipronil in eieren: geef voedselveiligheid topprioriteit

Commissie onderzoek fipronil in eieren: geef voedselveiligheid topprioriteit

Bedrijven in de eierketen, de NVWA en de ministeries van VWS en LNV hebben onvoldoende voorrang gegeven aan voedselveiligheid. Bedrijven in de eierketen maken hun wettelijke verantwoordelijkheid niet waar. Bij de NVWA krijgt voedselveiligheid te weinig aandacht. Politiek en bestuur hebben een te beperkte opvatting over hun eigen rol ten aanzien van voedselveiligheid en komen pas in actie als zich een incident of crisis voordoet. Dat zijn de belangrijkste conclusies uit het rapport van de Commissie onderz...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

29-6-2018

BROADLINE (Merial)

BROADLINE (Merial)

BROADLINE (Active substance: Fipronil/ S-methoprene/ Eprinomectin/ Praziquantel) - Centralised - Yearly update - Commission Decision (2018) 4164 of Fri, 29 Jun 2018

Europe -DG Health and Food Safety

30-4-2018

CERTIFECT (Merial)

CERTIFECT (Merial)

CERTIFECT (Active substance: (S)-Methoprene, Fipronil, Amitraz) - Withdrawal - Commission Decision (2018)2687 of Mon, 30 Apr 2018

Europe -DG Health and Food Safety